Efektivitas Tetes Mata Citicoline terhadap Perbaikan Lapang Pandang dan Ketebalan Lapisan Serabut Saraf Retina pada Glaukoma Primer Sudut Terbuka
DOI:
https://doi.org/10.55175/cdk.v51i2.1046Keywords:
Citicoline, glaucoma, eyedropsAbstract
Primary open-angle glaucoma (POAG) is the second leading cause of irreversible blindness worldwide with increasing prevalence. Oral citicoline has been shown to have a role in glaucoma; however, studies regarding citicoline eye drops for glaucoma are still limited. This is a critical appraisal of the literature on the effectiveness of citicoline in improving the mean deviation (MD) of the visual field and thickness of the retinal nerve fiber layer (RNFL) in POAG. A literature search was done on 4 databases: PubMed, Cochrane, Embase, and Scopus. From the 165 studies initially identified, 3 studies were qualified for critical review. Rossetti demonstrated significant MD (p=0.02) and RNFL (p=0.04) differences after 3 years of citicoline eye drops compared to placebo. Mirachtsis showed that after citicoline administration for 3 months there was a significant difference in RNFL (p=0.029), but no significant improvement in MD (p>0.05). Parisi showed an improvement in MD after 4 months (+0.56 dB) and 6 months (+0.18 dB) of citicoline administration. Citicoline eye drops have the potential to inhibit glaucoma progression by inhibiting RNFL loss, but further research is needed on visual field improvement.
Downloads
References
Primary Open-Angle Glaucoma - EyeWiki [Internet]. 2023 [cited: 2023 Jun 28]. Available from: https://eyewiki.aao.org/Primary_Open-Angle_Glaucoma
Zhang N, Wang J, Li Y, Jiang B. Prevalence of primary open angle glaucoma in the last 20 years: A meta-analysis and systematic review. Sci Rep. 2021;11(1):13762.
American Academy of Opthalmology. Glaucoma: Definitions and classification [Internet]. 2015 [cited: 2023 Jun 28]. Available from: https://www.aao.org/education/disease-review/glaucoma-definitions-classification
Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus. 2020;12(11):e11686.
Kementerian Kesehatan Republik Indonesia Pusat Data dan Informasi Kementerian Kesehatan RI. Infodatin: Situasi glaukoma di Indonesia [Internet]. 2019 [cited: 2023 Jun 28]. Available from: https://www.kemkes.go.id/downloads/resources/download/pusdatin/infodatin/infoDatin_glaukoma_2019.pdf
Evangelho K, Mogilevskaya M, Losada-Barragan M, Vargas-Sanchez JK. Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. Int Ophthalmol. 2019;39(1):259–71.
American Academy of Opthalmology. Glaucoma Eye Drops [Internet]. American Academy of Ophthalmology. 2023 [cited: 2023 Jun 28]. Available from: https://www.aao.org/eye-health/diseases/glaucoma-eyedrop-medicine
Sheybani A, Scott R, Samuelson TW, Kahook MY, Bettis DI, Ahmed IIK, et al. Open-angle Glaucoma: Burden of illness, current therapies, and the management of nocturnal IOP variation. Ophthalmol Ther. 2020;9(1):1–14.
Rossetti L, Iester M, Tranchina L, Ottobelli L, Coco G, Calcatelli E, et al. Can treatment with citicoline eyedrops reduce progression in glaucoma? The results of a randomized placebo-controlled clinical trial. J Glaucoma. 2020;29(7):513–20.
Sahin AK, Kapti HB, Uzun A. Effect of oral citicoline therapy on retinal nerve fiber layer and ganglion cell-inner plexiform layer in patients with primary open angle glaucoma. Int J Ophthalmol. 2022;15(3):483–8.
Lanza M, Gironi Carnevale UA, Mele L, Bifani Sconocchia M, Bartollino S, Costagliola C. Morphological and functional evaluation of oral citicoline therapy in chronic open-angle glaucoma patients: A pilot study with a 2-year follow-up. Front Pharmacol. 2019;10:1117.
Carnevale C, Manni G, Roberti G, Micera A, Bruno L, Cacciamani A, et al. Human vitreous concentrations of citicoline following topical application of citicoline 2% ophthalmic solution. PLoS One. 2019;14(11):e0224982.
Roberti G, Tanga L, Parisi V, Sampalmieri M, Centofanti M, Manni G. A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy. Indian J Ophthalmol. 2014;62(5):549–53.
OCEBM Levels of Evidence — Centre for Evidence-Based Medicine (CEBM), University of Oxford [Internet]. 2023 [cited: 2022 Jun 3]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
Critical Appraisal tools — Centre for Evidence-Based Medicine (CEBM), University of Oxford [Internet]. 2023 [cited: 2023 Jun 25]. Available from: https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools
Mirachtsis T, Theofilou G, Sorkou K, Lalias T, Marinopoulos K, Sioulis C. Randomized clinical study of the citicoline effect in glaucoma and glaucoma phacoemulsified patients. Acta Ophthalmologica [Internet]. 2019 [cited: 2023 Jun 29];97(S263). Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2019.5119
Parisi V, Centofanti M, Ziccardi L, Tanga L, Michelessi M, Roberti G, et al. Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2015;253(8):1327–40.
Rossetti L, Iester M, Tranchina L, Ottobelli L, Coco G, Calcatelli E, et al. Can treatment with citicoline eyedrops reduce progression in glaucoma? The results of a randomized placebo-controlled clinical trial. J Glaucoma. 2020;7:513–20.
Jasielski P, Piędel F, Piwek M, Rocka A, Petit V, Rejdak K. Application of citicoline in neurological disorders: A systematic review. Nutrients. 2020;12(10):3113.
Secades JJ, Gareri P. Citicoline: pharmacological and clinical review, 2022 update. Rev Neurol. 2022;75(s05):S1–89.
Grieb P. Neuroprotective properties of citicoline: Facts, doubts and unresolved issues. CNS Drugs. 2014;28(3):185–93.
Jünemann AGM, Grieb P, Rejdak R. [The role of citicoline in glaucoma]. Ophthalmologe. 2021;118(5):439–48.
Alasil T, Wang K, Yu F, Field MG, Lee H, Baniasadi N, et al. Correlation of retinal nerve fiber layer thickness and visual fields in glaucoma: A broken stick model. Am J Ophthalmol. 2014;157(5):953–9.
Geng W, Wang D, Han J. Trends in the retinal nerve fiber layer thickness changes with different degrees of visual field defects. J Ophthalmol. 2020;2020:e4874876.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Metta Dewi, Ariel Valentino Soetedjo
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.